Wells Fargo Maintains Overweight on Omnicell, Lowers Price Target to $50

Benzinga Newsdesk www.benzinga.com Negative 53.3%

Neg 53.3% Neu 0% Pos 0%

Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $55 to $50.